Ref ID: 19263
Author:
P. Merino, O. Zaragoza, M. Cuenca, J. Picazo
Author address:
Clinico San Carlos Hosp., Madrid, Spain, Natl. Ctr. for Microbiol., Madrid, Spain.
Full conference title:
53rd Interscience Conference on Antimicrobial Agents and Chemotherapy
Date: 10 September 2014
Abstract:
Background: Candidemia is a nosocomial infection with a high morbidity and mortality. Specific therapy must not be delayed as it affects prognosis. Guidelines recommend candins or lipid formulations of amphotericin B for initial treatment. Fluconazole in stable patients without azole-resistance risk factors. We studied the epidemiology of candidemia episodes in our hospital to identify species and susceptibility to nine antifungal, and mechanisms of resistance. Methods: We collected epidemiological and clinical data of 140 cases of candidemia. The identification of species was performed by sequencing the ribosomal DNA by oligonucleotides which amplify the ITS1-5.8-ITS2 region, further clustering (Infoquest software, Spanish Mycology Reference Lab database). Antifungal susceptibility testing was performed to Amphotericin B, Flucytosine, Fluconazole, Itraconazole, Voriconazole, Ravuconazole, Posaconazole, Caspofungin, Micafungin and Anidulafungin (EUCAST protocol). Amplification of the hot spots from the FSK1 gene was performed to Candida non-parapsilosis strains which MIC value for caspofungin was ≥ 0.5 μg/mL. Results: 24,1% patients were from oncohematology,24,03% ICU; 17,8%Surgery;14%InternalMedicine;10,9%Medical;6,2%Emergency; 3,1%neonatology (50,7% femail and 64,5 years average of age). 50% of the isolates were C.albicans, 25% C. parapsilosis, 10% C. glabrata and 5%
C. tropicalis. The rest of the isolates were 1.5%. A total of
15% of isolates tested showed decreased susceptibility in
vitro to fluconazole (MIC value >2 mg/L). 3% of C.
albicans were resistant in vitro to this azole. The DNA
sequence analysis of the HS1 and HS2 regions of the FKS1
gene revealed three strains of C. albicans presenting one
polymorphism at the HS1, but none of them involved any
change in the protein sequence. Conclusions: Half of the
candidemias were caused by non albicans strains (25%
C.parapsilopsis). We don’t find resistance to candinas in
non parapsilosis strains. 15% of isolates had decresead
susceptibility to fluconazol. Thus, we consider important to
individualize the choice of antifungal depending on each
case. We consider the importance of create surveillance
programs with these patients
Abstract Number: NULL
Conference Year: 2013
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a